Click Therapeutics Acquires Better Therapeutics, Expands into Obesity and Cardiometabolic Disease
What You Should Know:
– Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.
– Click’s expansion into cardiometabolic disease follows successful DTx development efforts in…
Continue Reading